Mozobil recall: Labeling Error
Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500…
Why was Mozobil recalled?
Labeling: Incorrect or Missing Lot and/or Exp. Date
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 5RZ002; Exp. 04/18
- Product
- Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured by: Genzyme Corporation, 500…
- Recalling firm
- Genzyme Corporation / Genzyme Biosurgery
- Quantity
- 9,530 vials
- Distribution
- nationwide
- Recall date
- September 28, 2016
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)